Fusion Antibodies PLC
LSE:FAB
Fusion Antibodies PLC
LSE:FAB
Price:
3.65 GBX
-2.67%
Market Closed
Updated:
Apr 28, 2024
Fusion Antibodies PLC
Operating Expenses
|
Fusion Antibodies PLC
Operating Expenses Peer Comparison
Comparables:
ONT
O
ORPH
DXRX
ERGO
HVO
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Fusion Antibodies PLC
LSE:FAB
|
Operating Expenses
-£2.9m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
Oxford Nanopore Technologies PLC
LSE:ONT
|
Operating Expenses
-£259.1m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
|
O
|
Open Orphan PLC
LSE:ORPH
|
Operating Expenses
-£42.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Diaceutics PLC
LSE:DXRX
|
Operating Expenses
-£16.2m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
|
|
Ergomed PLC
LSE:ERGO
|
Operating Expenses
-£41.1m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
|
hVIVO PLC
LSE:HVO
|
Operating Expenses
-£45.7m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
-29%
|
See Also
What is Fusion Antibodies PLC's Operating Expenses?
Operating Expenses
-2.9m
GBP
-2.9m
GBP
Based on the financial report for Sep 30, 2023, Fusion Antibodies PLC's Operating Expenses amounts to -2.9m GBP.
What is Fusion Antibodies PLC's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-5%
-5%
Over the last year, the Operating Expenses growth was 24%.
You don't have any saved screeners yet
